CompletedPhase 2Phase 3ACTRN12605000207617

Fish Oils (Omega 3) in ischaemic stroke

A Randomised, Placebo-Controlled Intervention Trial of Omega-3 PUFA, (Fish Oils), in People with Ischaemic Stroke

Sponsor

Health Research Council (New Zealand)

Enrollment

220 participants

Start Date

Jun 1, 2004

Study Type

Interventional

Conditions

Ischaemic Cerebrovascular Disease Ischaemic Cerebrovascular Stroke

Eligibility

Sex: Both males and femalesMin Age: 45 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Fish Oils (Omega 3) in ischaemic stroke. You may be eligible if you are aged 45 or older, with first-ever or recurrent ischaemic stroke. Participation may involve medical assessments, follow-up visits, and possibly receiving a study treatment or placebo.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Participants receive 3 gm of fish oil (containing omega-3 PUFAs) orally for the treatment group Participants are seen at 0 and 12 weeks for clinical assessments, anthropometry, venepuncture for haematological and biochemical analyses, assessment of compliance and the recording of adverse events. In addition, a telephone follow-up visit will be performed at 6 and 11 weeks to ascertain safety data (SAEs) and compliance to study treatment.

Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000207617